Skip to main content
. 2017 Mar 1;185(7):591–600. doi: 10.1093/aje/kww115

Table 3.

Estimated Nonresponse Rates in Young Adults (Aged 18–24 Years) at 3-Year Follow-up as a Function of Baseline Drug-Treatment Utilization, National Epidemiologic Survey on Alcohol and Related Conditions, United States, 2001–2002 and 2004–2005

Baseline Drug-Treatment Utilization No. of Respondents Weighted Nonresponse Rate, %a Rao-Scott Test
Test Statistica P Value
Any alcohol treatment
 No lifetime alcohol treatment (abstainer) 1,234 25.69 F(1.99, 129.35) = 3.476 0.034
 No lifetime alcohol treatment (drinker) 3,769 21.30
 History of alcohol treatment 162 23.90
AA or other 12-step meeting
 No lifetime AA/12-step meeting (abstainer) 1,234 25.69 F(1.93, 113.80) = 0.496 0.604
 No lifetime AA/12-step meeting (drinker) 62 19.58
 History of AA/12-step meeting 99 26.88
Any drug treatment
 No lifetime drug treatment (abstainer) 3,719 22.97 F(1.96, 127.43) = 0.785 0.456
 No lifetime drug treatment (drug user) 1,343 21.01
 History of drug treatment 131 22.73
NA or other 12-step meeting
 No lifetime NA/12-step meeting (abstainer) 3,719 22.97 F(1.99, 129.07) = 0.664 0.516
 No lifetime NA/12-step meeting (drug user) 66 27.38
 History of NA/12-step meeting 65 17.61

Abbreviations: AA, Alcoholics Anonymous; NA, Narcotics Anonymous.

a All weighted estimates and Rao-Scott tests use design information from wave 1 (2001–2002).